In chronic myelogenous leukemia (CML), SIRT1 overexpression was detected in CD34+ stem cells and implicated to increase CD34+ cell survival by suppressing TP53-mediated apoptosis of CML CSCs [52]. Here, TP53 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.